Literature DB >> 24235918

Evaluation of patients with Crimean-Congo hemorrhagic fever in Bolu, Turkey.

A Duran1, A Küçükbayrak, T Ocak, N I Hakyemez, T Taþ, M Karadađ, Z F Mengelođlu.   

Abstract

BACKGROUND: Crimean-Congo hemorrhagic fever (CCHF), which is associated with a high mortality rate in the Black Sea region of Turkey, has received increasing attention.
OBJECTIVE: In this study, the epidemiological features, clinical and laboratory findings, treatments, and outcomes of patients diagnosed with CCHF between 2006 and 2012 based on data obtained from the Bolu Provincial Directorate of Health (BPDH) were evaluated.
METHODS: BPDH data were reviewed for the period between 1 January 2006 and 31 July 2012. The locations where the tick had attached to the patient, the site of the tick bite on the patient's body, the dates of tick bite and removal, and the demographic characteristics of each patient were recorded. BPDH data on the total number of tick bites, patients with confirmed CCHF, and deaths due to CCHF in Bolu Province during the study period were also evaluated.
RESULTS: A total of 46 patients with CCHF and 38 patients without CCHF but who had been bitten by ticks were admitted to the BPDH. Of the patients with CCHF, 54.3% were female. The mean age of the patients was 46.88 ± 2.05 years (range, 1-79 years). The mortality rate was 8.82%. Patients were predominantly observed in June and July. When the patients were distributed according to their occupations, the majority was houswife (48.6%), followed by animal husbandry worker (27.0%), farmer (10.8%), health worker (5.4%), and other (8.1%). The symptoms of the patients with CCHF included fatigue (60.9%), fever (60.9%), and myalgia (60.9%). Of those patients with CCHF, 41.3% were determined to have a high fever.
CONCLUSIONS: The probability of developing CCHF decreased as the duration of tick attachment increased. Moreover, although the clinical presentation is important, it is not diagnostic. Physical examination and laboratory findings become more specific in later stages.

Entities:  

Keywords:  Black Sea; Crimean-Congo hemorrhagic fever virus

Mesh:

Year:  2013        PMID: 24235918      PMCID: PMC3824500          DOI: 10.4314/ahs.v13i2.5

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  32 in total

1.  Bichat clinical guidelines for bioterrorist agents.

Authors:  Philippe Bossi; Frank Van Loock; Anders Tegnell; Georgios Gouvras
Journal:  Euro Surveill       Date:  2004-12-15

Review 2.  Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis.

Authors:  Sibel Ascioglu; Hakan Leblebicioglu; Haluk Vahaboglu; K Arnold Chan
Journal:  J Antimicrob Chemother       Date:  2011-04-11       Impact factor: 5.790

3.  Congo/Crimean haemorrhagic fever in Iraq.

Authors:  S K Al-Tikriti; F Al-Ani; F J Jurji; H Tantawi; M Al-Moslih; N Al-Janabi; M I Mahmud; A Al-Bana; H Habib; H Al-Munthri; S Al-Janabi; K AL-Jawahry; M Yonan; F Hassan; D I Simpson
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

Review 4.  Hemorrhagic fever viruses as biological weapons: medical and public health management.

Authors:  Luciana Borio; Thomas Inglesby; C J Peters; Alan L Schmaljohn; James M Hughes; Peter B Jahrling; Thomas Ksiazek; Karl M Johnson; Andrea Meyerhoff; Tara O'Toole; Michael S Ascher; John Bartlett; Joel G Breman; Edward M Eitzen; Margaret Hamburg; Jerry Hauer; D A Henderson; Richard T Johnson; Gigi Kwik; Marci Layton; Scott Lillibridge; Gary J Nabel; Michael T Osterholm; Trish M Perl; Philip Russell; Kevin Tonat
Journal:  JAMA       Date:  2002-05-08       Impact factor: 56.272

5.  The lack of Crimean-Congo hemorrhagic fever virus antibodies in healthcare workers in an endemic region.

Authors:  Onder Ergonul; Herve Zeller; Aysel Celikbas; Basak Dokuzoguz
Journal:  Int J Infect Dis       Date:  2007-01       Impact factor: 3.623

Review 6.  Crimean-Congo hemorrhagic fever.

Authors:  Chris A Whitehouse
Journal:  Antiviral Res       Date:  2004-12       Impact factor: 5.970

7.  The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.

Authors:  Iftihar Koksal; Gurdal Yilmaz; Firdevs Aksoy; Hava Aydin; Ilknur Yavuz; Serap Iskender; Korhan Akcay; Sukru Erensoy; Rahmet Caylan; Kemalettin Aydin
Journal:  J Clin Virol       Date:  2009-12-03       Impact factor: 3.168

8.  [Respiratory lesions in Congo-Crimean hemorrhagic fever].

Authors:  I V Sannikova; V D Pacechnikov; V V Maleev
Journal:  Ter Arkh       Date:  2007       Impact factor: 0.467

9.  Crimean-Congo hemorrhagic fever: prevention and control limitations in a resource-poor country.

Authors:  Raymond A Smego; Arif R Sarwari; Amna Rehana Siddiqui
Journal:  Clin Infect Dis       Date:  2004-05-24       Impact factor: 9.079

Review 10.  Crimean-Congo haemorrhagic fever.

Authors:  Onder Ergönül
Journal:  Lancet Infect Dis       Date:  2006-04       Impact factor: 25.071

View more
  5 in total

1.  Evaluation of cases with a preliminary diagnosis of Crimean- Congo hemorrhagic fever and comparison of characteristics in patients admitted to a secondary care hospital in Kastamonu, Turkey.

Authors:  Hüseyin Can Hekimoğlu; Neşe Ateş Demirci
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Nodding syndrome, infections and sexuality.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

3.  Evaluation of Crimean-Congo hemorrhagic fever suspected cases admitted to a secondary care hospital in Kastamonu, Turkey between 2014-2017.

Authors:  Hasan Tahsin Gozdas
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

4.  Clinical and Molecular Epidemiology of Crimean-Congo Hemorrhagic Fever in Humans in Uganda, 2013-2019.

Authors:  Stephen Balinandi; Shannon Whitmer; Sophia Mulei; Luke Nyakarahuka; Alex Tumusiime; Jackson Kyondo; Jimmy Baluku; Joseph Mutyaba; Lawrence Mugisha; Maja Malmberg; Julius Lutwama; Trevor R Shoemaker; John D Klena
Journal:  Am J Trop Med Hyg       Date:  2021-10-18       Impact factor: 3.707

5.  Evaluation of seroprevalence and clinical and laboratory findings of patients admitted to health institutions in Gümüşhane with suspicion of Crimean-Congo hemorrhagic fever

Authors:  Esra Gürbüz; Abdurrahman Ekici; Ahmet Hakan Ünlü; Hasan Yılmaz
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.